Maternal serum levels of free β-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery

The purpose of this case–control study was to examine the association of first‐trimester concentrations of free β‐human chorionic gonadotropin (free β‐hCG) and pregnancy‐associated plasma protein A (PAPP‐A) in maternal serum with subsequent preterm delivery or small‐for‐gestational age (SGA) fetuses. We collected all the blood samples before chorionic villus sampling in the first trimester. Concentrations of free β‐hCG and PAPP‐A were expressed in multiples of the median (MOM) for gestational age. We compared the levels of both analytes in 73 SGA pregnancies (birth weight below the fifth percentile) with those in 292 normal controls, who were matched for gestational age, maternal age, parity, maternal weight, and smoking habits. We also compared the levels in 87 pregnancies with a preterm delivery (delivery before 37 completed weeks) with those in 348 matched controls. The median concentrations of PAPP‐A and free β‐hCG, expressed in MOMs, in the 73 SGA pregnancies were 0·83 and 0·95, respectively, compared with 0·98 and 1·01, respectively, in the 292 matched controls (P=0·08 and 0·19, respectively). In the 87 pregnancies with a preterm delivery, the median concentrations of PAPP‐A and free β‐hCG were 0·98 and 0·94, respectively, compared with 0·99 and 0·99, respectively, in the 348 matched controls (P=0·82 and 0·10, respectively). In contrast with the maternal serum analytes used in second‐trimester screening—alpha‐fetoprotein and human chorionic gonadotropin—this study showed that concentrations of PAPP‐A and free β‐hCG in the first trimester were not associated with subsequent fetal growth retardation or preterm delivery. © 1998 John Wiley & Sons, Ltd.